Skip to content

Quantitative Assessment of the Impact of Superficial Sensory Abnormalities on Psychiatric Symptoms in Autism Spectrum Disorder

Quantitative Assessment of the Impact of Superficial Sensory Abnormalities on Psychiatric Symptoms in Autism Spectrum Disorder - Assessment of thermal pain perception in children with ASD

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000050998
Enrollment
75
Registered
2023-05-08
Start date
2022-12-28
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism spectrum disorder

Interventions

None listed

Sponsors

Shiga University of Medical Science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Case group: Individuals considered by clinicians to have a diagnosis of autism spectrum disorder, and their guardian. Control group: Individuals who have never been diagnosed with a mental disorder, including developmental disabilities, and their guardian. 2. Age: Child 10 to 17 years old (At the time of registration) 3. Individuals who can understand the explanatory document of the study and obtain the written consent based on the free will of the patient and their guardian

Exclusion criteria

Exclusion criteria: 1. Case group: Individuals with comorbid psychiatric disorders other than attention-deficit/hyperactivity disorder (ADHD) and intellectual developmental disorders (IDD) 2. Individuals with severe pain, acute trauma, or peripheral nerve paralysis in the non-dominant forearm for some reason 3. Individuals who were deemed unsuitable as study participants by the study's lead clinicians or co-clinicians

Design outcomes

Primary

MeasureTime frame
- Objective Thermal Pain Assessment: Cold and warm detection thresholds: CDT/WDT, Cold and heat pain thresholds: CPT/HPT in Quantitative Sensory Testing - Scores of Psychological Test: Sensory Profile: SP, Conners3, Social Responsiveness Scale: SRS-2, Child Behavior Checklist: CBCL, General Health Questionnaire: GHQ-28, Spence Children's Anxiety Scale: SCAS, Depression Self-Rating Scale for Children: DSRS-C, Short- Form McGill Pain Questionnaire-2: SF-MPQ-2, Pediatric Daytime Sleepiness Scale: PDSS

Secondary

MeasureTime frame
- Evaluation of Placebo Analgesia: placebo-QST - Background of participants

Countries

Japan

Contacts

Public ContactFumi Masuda

Shiga University of Medical Science Department of Psychiatry

fumi@sums-psychiatry.com077-548-2291

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026